Number of Registered Nurses Rebounds Following Pandemic Decline
By Lori Solomon HealthDay Reporter
THURSDAY, Feb. 22, 2024 -- There was a rebound in the total size of the U.S. registered nurse (RN) workforce during 2022 and 2023, according to a study published online Feb. 16 in JAMA Health Forum.
David I. Auerbach, Ph.D., from Brandeis University in Waltham, Massachusetts, and colleagues assessed whether the current and projected number of RNs in the United States changed after the COVID-19 pandemic. The analysis included employment data from the U.S. Bureau of the Census Current Population Survey for employed RNs aged 23 to 69 years from 1982 through 2023.
The researchers found that after a sharp decline in 2021, RN employment recovered and the total number of full-time equivalent RNs in 2022 and 2023 was 6 percent higher than in 2019 (3.35 million versus 3.16 million). By 2035, the size of the RN workforce was projected to increase by roughly 1.2 million full-time equivalents to 4.56 million, close to prepandemic forecasts. RNs aged 35 to 49 years, who are projected to compose nearly half (47 percent) of the RN workforce in 2035, will drive this growth.
"Overall, this forecast suggests that the pandemic’s impact on employed RNs, at least thus far, is unlikely to have a significant impact on the future growth of the overall RN workforce," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Further Support and Information on COVID-19
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.